Paroxysmal supraventricular tachycardias

Journal of Emergency Medicine

Volumn 14, Issue 1, 1996, Pages 39-51

  Lowenstein, Steven R ^a,b   Halperin, Blair D ^b   Reiter, Michael J ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

adenosine; reentry; supraventricular tachycardia; Wolff Parkinson White syndrome

Indexed keywords

DISEASE CLASSIFICATION; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART AUTOMATICITY; HEART ELECTROPHYSIOLOGY; HUMAN; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; QRS COMPLEX; REENTRY ARRHYTHMIA; REVIEW; WOLFF PARKINSON WHITE SYNDROME;

EID: 0029944488     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/0736-4679(95)02061-6     Document Type: Note

References (48)

1. Lowenstein SR, Harken AH. A wide, complex look at cardiac dysrhythmias. J Emerg Med. 1987;5(6):519-31.
2. Wit AL. Cellular electrophysiologic mechanisms of cardiac arrhythmias. Cardio Clin. 1990;8(3):393-409.
3. Hoffman BF, Rosen MR. Cellular mechanisms for cardiac arrhythmias. Circ Res. 1981;49(1):1-15.
4. Schwartz M, Lowenstein SR, Rodman D. Recognition and treatment of multifocal atrial tachycardia: a critical review. J Emerg Med. 1994;12(3):353-60.
5. Wu D, Denes P, Amat-Y-Leon F, et al. Clinical, electrocardiographic and electrophysiologic observations in patients with paroxysmal supraventricular tachycardia. Am J Cardiol. 1978; 41:1045-51.
6. Sager PT, Bhandari AK. Narrow complex tachycardias. Differential diagnosis and management. Cardiol Clin. 1991;9(4):619-40.
7. Wu D. Supraventricular tachycardias. JAMA. 1983;249(24): 3357-60.
8. Rosen MR. The links between basic and clinical cardiac electrophysiology. Circulation. 1988;77(2):251-63.
9. Benditt DG, Goldstein MA, Reyes WJ, Milstein S. Supraventricular tachycardias: mechanisms and therapies. Hosp Pract. 1988;23(8):161-73,176-80,183-5.
10. Wellens HJ, Brugada P, Penn OC. The management of preexcitation syndromes. JAMA. 1987;257(17):2325-33.
11. Ganz LI, Friedman PL. Supraventricular tachycardia. N Engl J Med. 1995;332:162-173.
12. Josephson ME, Wellens HJ. Differential diagnosis of supraventricular tachycardia. Cardiol Clin. 1990;8(3):411-42.
13. Bar FW, Brugada P, Dassen WR, Wellens HJ. Differential diagnosis of tachycardia with narrow QRS complex (shorter than 0.12 second). Am J Cardiol. 1984;54(6):555-60.
14. Mauritson DR, Winniford MD, Walker WS, Rude RE, Cary JR, Hillis LD. Oral verapamil for paroxysmal supraventricular tachycardia: a long-term, double-blind randomized trial. Ann Intern Med. 1982;96(4):409-12.
15. Flagel KM. From delirium cordis to atrial fibrillation: historical development of a disease concept. Ann Intern Med. 1995; 122:867-73.
16. Wellens HJ, Durrer D. Effect of digitalis on atrioventricular conduction and circus-movement tachycardias in patients with Wolff-Parkinson-White syndrome. Circulation. 1973;47(6): 1229-33.
17. Gulamhusein S, Ko P, Carruthers SG, Klein GJ. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil. Circulation. 1982;65(2):348-54.
18. Jacob AS, Nielsen DH, Gianelly RE. Fatal ventricular fibrillation following verapamil in Wolff-Parkinson-White syndrome with atrial fibrillation. Ann Emerg Med. 1985;14(2):159-60.
19. McGovern B, Garan H, Ruskin JN. Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome. Ann Intern Med. 1986;104(6):791-4.
20. Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N Engl J Med. 1979;301(20):1080-5.
21. Marriott HJL. Practical electrocardiography (8th edn). Baltimore: Williams and Wilkins; 1988.
22. Waxman MB, Wald RW, Sharma AD, Huerta F, Cameron DA. Vagal techniques for termination of paroxysmal supraventricular tachycardia. Am J Cardiol. 1980;46(4):655-64.
23. Waxman B, Bonet JF, Finley JP, Wald RW. Effects of respiration and posture on paroxysmal supraventricular tachycardia. Circulation. 1980;62(5):1011-20.
24. Ornato JP, Hallagan LF, Reese WA, et al. Treatment of paroxysmal supraventricular tachycardia in the emergency department by clinical decision analysis. Am J Emerg Med. 1988;6(6):555-60.
25. DiMarco JP, Miles W, Akhtar M, et al. Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group. Ann Intern Med. 1990;113(2):104-10.
26. Bastulli JA. Stroke as a complication of carotid sinus massage. Crit Care Med. 1985;869.
27. Mehta D, Wafa S, Ward DE, Camm AJ. Relative efficacy of various physical manoeuvres in the termination of junctional tachycardia. Lancet. 1988;1(8596):1181-5.
28. Camm AJ, Garratt CJ. Adenosine and supraventricular tachycardia. N Engl J Med. 1991;325(23):1621-9.
29. Kuhn M, Schriger DL. Verapamil administration to patients with contraindications: is it associated with adverse outcomes? Ann Emerg Med. 1991;20(10):1094-9.
30. Rankin AC, McGovern BA. Adenosine or verapamil for the acute treatment of supraventricular tachycardia? Ann Intern Med. 1991;114(6):513-5.
31. McCabe JL, Adhar GC, Menegazzi JJ, Paris PM. Intravenous adenosine in the prehospital treatment of paroxysmal supraventricular tachycardia. Ann Emerg Med. 1992;21(4):358-61.
32. Exner DV, Muzyka T, Gillis AM. Proarrhythmia in patients with the Wolff-Parkinson-White syndrome after standard doses of intravenous adenosine. Ann Intern Med. 1995;122:351-2.
33. Adenosine and the diagnosis of tachycardias. Lancet. 1992;339(8791):464-5.
34. Cairns CB, Niemann JT. Intravenous adenosine in the emergency department management of paroxysmal supraventricular tachycardia. Ann Emerg Med. 1991;20(7):717-21.
35. Rankin AC, Oldroyd KG, Chong E, Rae AP, Cobbe SM. Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J. 1989;62(3):195-203.
36. DiMarco JP, Sellers TD, Lerman BB, Greenberg ML, Berne RM, Belardinelli L. Diagnostic and therapeutic use of adenosine in patients with supraventricular tachyarrhythmias. J Am Coll Cardiol. 1985;6(2):417-25.
37. Garratt CJ, Antoniou A, Griffith MJ, Ward DE, Camm AJ. Use of intravenous adenosine in sinus rhythm as a diagnostic test for latent preexcitation. Am J Cardiol. 1990;65(13):868-73.
38. Stewart RB, Bardy GH, Greene HL. Wide complex tachycardia: misdiagnosis and outcome after emergent therapy. Ann Intern Med. 1986;104(6):766-71.
39. Dancy M, Camm AJ, Ward D. Misdiagnosis of chronic recurrent ventricular tachycardia. Lancet. 1985;2(8450):320-3.
40. Buxton AE, Marchlinski FE, Doherty JU, Flores B, Josephson ME. Hazards of intravenous verapamil for sustained ventricular tachycardia. Am J Cardiol. 1987;59(12):1107-10.
41. Rankin AC, Rae AP, Cobbe SM. Misuse of intravenous verapamil in patients with ventricular tachycardia. Lancet. 1987; 2(8557):472-4.
42. Griffith MJ, Linker NJ, Ward DE, Camm AJ. Adenosine in the diagnosis of broad complex tachycardia. Lancet. 1988;1 (8587):672-5.
43. Sharma AD, Klein GJ, Yee R. Intravenous adenosine triphosphate during wide QRS complex tachycardia: safety, therapeutic efficacy, and diagnostic utility. Am J Med. 1990;88(4):337-43.
44. Lerman BB, Belardinelli L, West GA, Berne RM, DiMarco JP. Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity. Circulation. 1986;74(2):270-80.
45. Pritchett EL, McCarthy EA, Lee KL. Clinical behavior of paroxysmal atrial tachycardia. Am J Cardiol. 1988;62(6):3D-9D.
46. Sintetos AL, Roark SF, Smith MS, McCarthy EA, Lee KL, Pritchett EL. Incidence of symptomatic tachycardia in untreated patients with paroxysmal supraventricular tachycardia. Arch Intern Med. 1986; 146(11):2205-9.
47. Prystowsky EN. Indications for intracardiac electrophysiologic studies in patients with supraventricular tachycardia. Circulation. 1987;75(4 Pt 2):III119-24.
48. Jackman WM, Beckman KJ, McClelland JH, et al. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med. 1992;327(5):313-8.